PEDIATRIX MEDICAL GROUP INC (MD)
Health Care · Healthcare Services - Physician Groups · NYSE
Pediatrix Medical Group is a leading provider of specialized maternal-fetal and pediatric physician services in the United States.
What PEDIATRIX MEDICAL GROUP INC does
Pediatrix Medical Group is a national medical group that provides physician and other clinical services in neonatal, maternal-fetal, pediatric, and other pediatric subspecialties. The company operates through a network of affiliated physician practices, delivering integrated care to infants, children, and their families across various clinical settings.
Themes: healthcare services, neonatal care, pediatric subspecialties, clinical services
Fundamentals
- Price$26.24 as of 2026-10-08 close
- Market cap$2.1B as of 2026-07-31 (share count; price 2026-10-08)
- 1-year return+53.2% 2025-10-08 close $17.13 → 2026-10-08 close $26.24
- P/E12.60 as of 2026-10-08
- ROE+19.1% FY2025, SEC XBRL
- Debt / equity0.66 as of 2026-09-03
- Revenue growth (YoY)+0.5% as of 2026-09-03
- Beta0.73 as of 2026-09-03
- Last reported earnings2026-08-04 SEC EDGAR Form 8-K (Item 2.02)
How MD compares in its sector
- price-to-earnings ratiobottom 25% 185 covered Health Care peers, as of 2026-10-08
- return on equitytop 25% 510 covered Health Care peers, as of 2026-09-03
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
MD is not currently in any published Top 10 list. Its scores are below.
Top 10 score
54.7 #482 of 1,379 scored · #55 of 151 in Health Care
Trend 81st (it is 6.1% below its highest point of the past year) and valuation 77th (price to earnings 12.6, price to book 2.4); weakest is growth (16th, revenue growth year over year 0.5%).
Scores as of 8 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
How PEDIATRIX MEDICAL GROUP INC looks technically
PEDIATRIX MEDICAL GROUP INC (MD) is trading 12.4% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 277 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 10, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 51, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 1 trading day ago (its momentum flipped positive). It made a new 20-day low about 16 trading days ago. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 9% of the past ~6 months), which often precedes a bigger move.
Trend
8
| Distance from the 200-day | it is trading 12.4% above its 200-day average, the long-term trend line — a longer-term uptrend | +12.4% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $26.34 | $26.34 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $23.35 | $23.35 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Wave structure | its recent swings can be read as a completed three-part downward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes below 25.4. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible three-wave downward correction, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 277 trading days ago — a "golden cross", a bullish long-term signal | 277 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 10, below the 25 that marks a real trend) | 9.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 51, neither overbought (above 70) nor oversold (below 30) | 51.3 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($25.30 to $26.82) — its "stochastic" reading is 62 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 61.8 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 1 trading day ago (its momentum flipped positive) | 1 session |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $27.94 | $27.94 |
|---|---|---|
| From the 52-week high | it is 6.1% below its 52-week high (its highest price of the past year) | -6.1% |
| Above the 52-week low | it is 67.1% above its 52-week low (its lowest price of the past year) | +67.1% |
| Below the 52-week high | it is 6.1% below its highest point of the past year | 6.1% |
| Since a 20-day breakout | it made a new 20-day low about 16 trading days ago | 16 sessions |
| Since a 55-day breakout | it is trading within its recent 55-day range, with no fresh breakout up or down | 0 sessions |
| All-time high | its highest closing price on record is $86.09 (set on 2015-08-18) | $86.09 |
| Given back of the 52-week move | over the past year its closes ranged ($15.80 to $27.39), and it has given back only a small part of its rise from last year’s low — 10% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $19.86 to $20.23. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 9.9% |
| From the all-time high | it is 69.5% below its all-time high | -69.5% |
| Nearest price level | it is trading 3.3% below a resistance level at $27.09 — a price it turned at three times since 2026-08-07, most recently on 2026-09-28. Since 2024-10-08 it has 16 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +3.3% |
| All-time low | its lowest closing price on record is $6.62 (set on 2024-07-09) | $6.62 |
| Above the all-time low | it is 296.4% above its all-time low | +296.4% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 9% of the past ~6 months), which often precedes a bigger move | 9th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.7948 between its high and its low — about 3.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.7948 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $25.34 and $26.81 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $25.34 – $26.07 – $26.81 |
| Typical daily range (% of price) | its price moves about 3.0% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.0% |
| Stretch from the 200-day average | it is trading 3.6 daily ranges above its 200-day average price (12.4% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.6 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.88× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
3
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|---|---|
| Since a bullish engulfing | 9 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 9 sessions ago |
| Since a bearish engulfing | 6 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 6 sessions ago |
Price gaps
2
| Gap at the open | it opened on 2026-10-08 0.5% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.5% |
|---|---|---|
| Gap filled | a 10.3% gap down opened on 2026-08-04 has been "filled" 46 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 46 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 3.6 percentage points (the stock lost 2.6% while the market gained 1.0%) | -3.6% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 5.9 percentage points (the stock lost 2.1% while the market gained 3.8%) | -5.9% |
| vs market, 6 months | over the past 6 months this stock beat the market by 3.5 percentage points (the stock gained 21.0% while the market gained 17.5%) | +3.5% |
| vs market, 12 months | over the past 12 months this stock beat the market by 38.2 percentage points (the stock gained 53.2% while the market gained 15.0%) | +38.2% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bearish state — these describe past price behaviour, not a forecast | 0 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 1.9% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thin, spanning 1.8% of the share price, which is taken to mean a barrier that gives way easily. | +1.9% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 12% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $23.43 — a volume-weighted average of daily closes over 191 sessions, not a true tick-by-tick VWAP. | +12.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is sitting right on the average price paid since it last reported on 2026-07-15 (its 8-K), so the typical buyer over that stretch is roughly break-even. That average is $26.24 — a volume-weighted average of daily closes over 61 sessions, not a true tick-by-tick VWAP. | -0.0% |
Ascending triangle, either side — forming · the lower entry $25.96 · 67 sessions in
Double top, bearish — forming · entry $24.71 · 51 sessions in
Price levels it has turned at before
MD last closed at $26.24 on 2026-10-08. Since 2024-10-08 it has turned at 16 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $27.09 | Resistance | 3.3% above the last close | turned there three times · 2026-08-07 to 2026-09-28 |
| $25.14 | Support | 4.2% below the last close | turned there six times · 2025-11-28 to 2026-10-01 |
| $27.75 | Resistance | 5.8% above the last close | turned there twice · 2026-07-07 to 2026-09-10 |
| $23.77 | Support | 9.4% below the last close | turned there twice · 2026-04-28 to 2026-07-15 |
| $22.85 | Support | 12.9% below the last close | turned there four times · 2025-12-16 to 2026-08-04 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part downward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $25.40.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 3 labellings that survived the rules, counting shorter readings of the same bars.
This reading has stood for 3 trading days, since 2026-10-06.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · MACD just crossed bullish (12/26/9) · in a Bollinger Band volatility squeeze · trendless / choppy (low ADX) · Trading above the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · macd · breakout · bollinger bands
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$26.33 range $21.00 – $28.00; median $28.00
Analyst estimates, as of 2026-10-03. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for MD
- Consensus EPS estimate$0.6497 next reporting period, as of 2026-10-03
- Estimate change, 30 days$0.00 (0.0%) from $0.6497, on 2026-08-29, 35-day window
- Readings revised upward13% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Significant reliance on government and third-party reimbursement programs for a majority of revenue.","Exposure to professional liability claims inherent in providing medical services.","Integration risks associated with acquiring and managing medical practices."]
What changed in the latest 10-Q
AI-assisted comparison of MD's 10-Q filed 2026-05-05 against the prior one filed 2025-11-03.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-05-05) adds reference to '2025 Form 10-K' filed February 19, 2026, replacing older reference to '2024 Form 10-K' filed February 20, 2025
- Newer filing adds 'or government-funded' to describe GHC Programs as 'government-sponsored or government-funded healthcare programs'
- Newer filing adds text regarding IDR enforcement: 'though providers have had difficulty enforcing IDR awards against insurers'
- Newer filing adds reference to 'the U.S. Department of Labor' as an enforcement agency for surprise billing violations
- Removed:
- Older filing (2025-11-03) contains entire 'Office-Based Practice Exits' section describing exits of office-based practices and primary/urgent care service line; this section is removed in newer filing
- Older filing includes phrase 'or by states, one or both of which' regarding enforcement agencies; newer filing changes this to 'or by states, one or multiple of which'
- Reworded:
- Comparison period changed from 'three months ended September 30, 2025' in older filing to 'three months ended March 31, 2026' in newer filing
- Comparison year changed from 'September 30, 2024' in older filing to 'March 31, 2025' in newer filing
- Description of network services changed from 'We also provide services across multiple other pediatric subspecialties' in older filing to 'Our network also includes other pediatric subspecialists' in newer filing
- Enforcement language changed from 'Centers for Medicare and Medicaid Services or by states' in older filing to 'Centers for Medicare and Medicaid Services, the U.S. Department of Labor, or by states' in newer filing
- IDR outcome language expanded from 'may not affect an insurer's future offers of payment' in older filing to include 'though providers have had difficulty enforcing IDR awards against insurers' in newer filing
- Notes:
- Older filing text appears truncated at end of Healthcare Reform section; comparison limited to available text
- Page number '13' appears in both filings but at different positions relative to content
- All changes are factual differences between the two quarterly filings for different reporting periods
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 180 days · read to 2026-10-040 buys · 1 sell ($855665) — 1 selling insider
Most recent open-market transaction: 2026-05-13. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about MD's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding MD as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 19,276,209
- Reported value $488,266,383
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 2 increased, 2 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about MD's institutional holders → See what each manager we track holds →
Short interest (FINRA)
MD had 4,730,174 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
MD had 5.82% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 6.9 days to cover at the same settlement.
- Reported short interest (shares) 4,730,174
- Short interest (% of shares outstanding) 5.82%
- Prior settlement (shares) 4,817,490
- Reported change -1.81%
- Days to cover (reported) 6.9
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Envision Healthcare
- TeamHealth
- MEDNAX Services (Internal/Legacy)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
PEDIATRIX MEDICAL GROUP INC is found in…
Frequently asked questions
What does PEDIATRIX MEDICAL GROUP INC (MD) do?
Pediatrix Medical Group is a national medical group that provides physician and other clinical services in neonatal, maternal-fetal, pediatric, and other pediatric subspecialties. The company operates through a network of affiliated physician practices, delivering integrated care to infants, children, and their families across various clinical settings.
What sector is PEDIATRIX MEDICAL GROUP INC (MD) in?
PEDIATRIX MEDICAL GROUP INC (MD) is classified in the Health Care sector. Its industry is Healthcare Services - Physician Groups. It trades on NYSE.
Who are PEDIATRIX MEDICAL GROUP INC's (MD) competitors?
Notable peers of PEDIATRIX MEDICAL GROUP INC (MD) include Envision Healthcare, TeamHealth and MEDNAX Services (Internal/Legacy). This peer set is informational only — not financial advice.
Is PEDIATRIX MEDICAL GROUP INC (MD) overbought or oversold right now?
PEDIATRIX MEDICAL GROUP INC (MD) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 51, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on MD come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.